
How Ivermectin Became Right-Wing Aspirin
Remember ivermectin? The animal-deworming medication was used so avidly as an off-label COVID treatment during the pandemic that some feed stores ended up going out of stock. (MUST SHOW A PIC OF YOU AND YOUR HORSE, a sign at one demanded of would-be customers in 2021.) If you haven't heard about it since, then you've existed blissfully outside the gyre of misinformation and conspiracies that have come to define the MAGA world's outlook on medicine. In the past few years, ivermectin's popularity has only grown, and the drug has become a go-to treatment for almost any ailment whatsoever. Once a suspect COVID cure, now a right-wing aspirin.
In fact, ivermectin never really worked for treating SARS-CoV-2 infections. Many of the initial studies that hinted at a benefit turned out to be flawed and unreliable. By 2023, a series of clinical trials had already proved beyond a doubt that ivermectin won't reduce COVID symptoms or mortality. But these findings mattered little to its fans, who saw the drug as having earned the status of dissident antiviral —a treatment that they believed had been suppressed by the medical establishment. And if ivermectin was good enough to be rejected by mainstream doctors as a cure for COVID, health-care skeptics seemed to reason, then surely it must have a host of other uses too.
As a physician who diagnoses cancer, I have come across this line of thinking in my patients, and found that some were using ivermectin to treat their life-threatening tumors. Nicholas Hornstein, a medical oncologist in New York City, told me that he's had the same experience: About one in 20 of his patients ask about the drug, he said. He remembers one woman who came into his office with a tumor that was visibly protruding from her abdomen, having swapped her chemotherapy for some ivermectin that she'd picked up at a veterinary-supply store. 'It's going to work any day now,' he says she told him when he tried to intervene.
The idea that ivermectin could be a cancer-fighting agent does have some modest basis in reality: Preliminary studies have suggested that antiparasitic medications might inhibit tumor growth, and at least one ongoing clinical trial is evaluating ivermectin's role as an adjunct to cancer treatment. That study has enrolled only nine patients, however, and the results so far show that just one patient's tumor actually shrank, according to a recent scientific abstract. But these meager grounds for hope now support a towering pile of expectations.
Cancer is just one of many illnesses that ivermectin is supposed to heal. According to All Family Pharmacy, a Florida-based company that promotes the compound to fans of Donald Trump Jr., Dan Bongino, Matt Gaetz, and Laura Ingraham on their podcasts and shows, the drug has 'anti-inflammatory properties that could help keep the immune system balanced in fighting infection.' (The company did not respond to a request for comment.) In sprawling Facebook groups devoted to ivermectin's healing powers, the claims are more extreme: The drug can combat a long list of conditions, members say, including Alzheimer's disease, heart disease, diabetes, autism, carpal tunnel syndrome, crow's feet, brain fog, and bee stings.
As a medication that supposedly was censored by elites—if not canceled outright by woke medicine and Big Pharma—ivermectin has become a symbol of medical freedom. It's also a MAGA shibboleth: Republican-leaning parts of the country helped drive an astounding 964 percent increase in prescriptions for the drug early in the pandemic, and GOP members of Congress have used their official posts to advocate for its benefits. Ivermectin can now be purchased without a prescription in Arkansas and Idaho, and other states are considering similar measures.
Health and Human Services Secretary Robert F. Kennedy Jr. has been a particularly strong proponent. In his 2021 book about the pandemic, Kennedy referred to the 'massive and overwhelming evidence' in ivermectin's favor, and invoked its 'staggering, life-saving efficacy.' He also argued at great length that the pharmaceutical industry—with the support of Anthony Fauci and Bill Gates—had engaged in a historic crime by attempting to discourage its use. Jay Bhattacharya, the director of the National Institutes of Health, has similarly backed the conspiracy theory that the use of ivermectin was dismissed by 'the powers that be' in an apparent ploy to ease the approval of COVID vaccines. (Not everyone in the current administration is a fan: Before he became the FDA's vaccine czar, the oncologist Vinay Prasad publicly disputed Kennedy's views on ivermectin, and earlier this year he called its use for cancer 'the right's version of masking on the airplane and praying to Lord Fauci.') In response to questions about Kennedy's and Bhattacharya's current views on ivermectin, the HHS press secretary Emily Hilliard told me that they 'continue to follow the latest scientific research regarding therapeutic options for COVID-19 and other illnesses.' She did not respond to questions about Prasad.
The idea of using antiparasitic drugs as cancer treatments was already taking hold by the late 2010s, Skyler Johnson, a Utah radiation oncologist who studies medical misinformation, told me. In January 2017, a man with lung cancer named Joe Tippens started on a dewormer called fenbendazole, which had been suggested to him by a veterinarian. Daniel Lemoi, who had Lyme disease, had started taking ivermectin in 2012 after reading a paper on the genetic similarities between humans and horses. Tippens would go on to achieve global fame among desperate cancer patients, and Lemoi became an ivermectin influencer during the pandemic.
Since then, a gaggle of dubious doctors has worked to bolster the credibility of deworming drugs within alternative medicine and anti-vaccine circles. Their underlying pitch has become familiar in the past few years: Health experts can't be trusted; the pharmaceutical industry is suppressing cheap cures; and patients deserve the liberty to choose their own medical interventions. For the rest of the medical establishment, the worldview this entails is straining doctor-patient relationships. Johnson told me that many of his patients are now skeptical of his advice, if not openly combative. One cancer patient accused Johnson of bias when he failed to recommend ivermectin. The drug is so cheap and effective, this patient had concluded, that Johnson would be out of a job if everyone knew about it. (Johnson told me that he offers patients 'the best possible treatment, no matter the financial incentive.') Ivermectin has become a big business in its own right. Online pharmacies and wellness shops are cashing in on the deworming craze, with one offering parasite cleanses for $200 a month. Meanwhile, fringe doctors can charge patients who have cancer and other diseases thousands of dollars to prescribe such treatments.
Johnson's own experience suggests that the cult of ivermectin is growing larger. He told me that he's seen his patients' interest in the drug explode since January, when the actor Mel Gibson went on Joe Rogan's podcast and claimed that three of his friends had beat back their advanced tumors with ivermectin and fenbendazole, among various other potions. 'This stuff works, man,' Gibson said. Meanwhile, in the ivermectin Facebook groups—including one with close to 300,000 members—the public can read posts from a woman with breast cancer considering using ivermectin in lieu of hormone treatments; a leukemia patient who has given up on chemotherapy to ' see what happens ' with antiparasitic drugs; or a concerned aunt wondering if the drugs might help her little niece with Stage 4 cancer.
But ivermectin advocacy is most disturbing in its totalizing form, wherein parasites—which is to say, the pathogens against which the drug truly is effective—are reimagined as the secret cause of many other unrelated problems. In the Facebook groups, members will share images of what they say are worms that have been expelled from their bodies by treatment. (This phenomenon brings to mind a different disease entirely: delusional parasitosis.) One recent post from the daughter of a Stage 4 lung-cancer patient showed a bloody glob that had 'dropped down into her mouth.' Commenters debated whether this might be a worm or something else. 'Blood clot from Covid vax?' one suggested. A few days later, the daughter gave an update: Her mom had gone to see the doctor, who informed her that she'd likely coughed up a piece of her own lung.
The whole exchange provides a sad illustration of this delirious and desperate time. Before it turned into a conservative cure-all, ivermectin was legitimately a wonder drug for the poorest people on Earth. Since its discovery in 1973, it has become a leading weapon in the fight against horrific infections such as river blindness and elephantiasis. Yet now that substantial success seems to have given birth to a self-destructive fantasy.
A decade ago, the co-discoverers of ivermectin—William Campbell and Satoshi Ōmura—were awarded a Nobel Prize in recognition of their contribution to reducing human suffering. In his formal lecture to the Academy, Campbell offered some reflections on the simple science that gave rise to the treatment, and to its wide array of applications. But his speech contained a warning, too, that any medicine that works so broadly and so well runs the risk of being handed out too often. The more benefits that such a drug provides, he told the audience in Stockholm, 'the more we must guard against the hazards of indiscriminate use.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
China launches first-ever invasive brain-computer interface clinical trial — Tetraplegic patient could skillfully operate racing games after just three weeks
When you buy through links on our articles, Future and its syndication partners may earn a commission. China's first in-human clinical trials of an invasive brain-computer interface (BCI) have launched, according to state media reports. This makes China second in the BCI race after the U.S., with its Neuralink technology, to enter the clinical trial phase for invasive BCI technology. Ahead of upcoming larger-scale trials, this new BCI from the Shanghai-based Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) already seems to be a success. The country's Global Times states that a tetraplegic patient has already been using its BCI to control a computer, play racing games, play chess, and more. "Now I can control the computer with my thoughts. It feels like I can move at will," said the unnamed tetraplegic to Global Times. Some background to the patient's condition is provided by the source. Apparently, the patient lost both arms and both legs in a high-voltage electrical accident 13 years ago. The man received an implant on March 25. Recovery was speedy, and just two to three weeks later, he was 'able to control electronic devices with his mind, skillfully operating racing games, chess, and other programs,' says the source. It isn't that long ago, but the report assures that 'no infection or electrode failure reported to date.' Progressing from computer interaction, the scientific team hopes to let its first patient get involved with robotic arm movement control trials. Added dexterity like this could enhance the patient's quality of life. Longer-term plans involve interactions and training with robots, and similar intelligent devices that span the computer–physical realms. The Chinese state media reports aren't without their characteristic boasts. Comparing the new CEBSIT BCI with Neuralink, they say the former has 'a cross-sectional area only 1/5 to 1/7 that of Neuralink's electrodes and flexibility over 100 times greater.' It adds that the neural electrodes used are the smallest and most flexible in the world. Their size and flexibility are better for the patient, so they barely perceive the implant's presence. Moreover, such compact BCIs will minimize damage to surrounding brain tissue and provide better prognosis over the longer term. Overall, the CEBSIT implant is said to be 26mm in diameter and under 6mm thick. With larger-scale clinical trials now greenlit, BCI systems such as this one from CEBSIT are expected to gain regulatory approval and enter the market in China by 2028. If these trials are a fair indicator of BCI benefits, they could 'significantly improve the quality of life for millions of patients with complete spinal cord injuries, bilateral upper limb amputations and amyotrophic lateral sclerosis,' notes the Global Times. We were a little surprised by the 'first' claims from CEBSIT today. Previously, we have reported another Chinese BCI project that seemed to be in its advanced stages. In April, we covered the news that a patient in China had been enjoying playing complex PC games such as Black Myth: Wukong and Honor of Kings using the Beinao-1 BCI implant. However, more recent reports suggest the Beinao-2 is being tested in monkeys and will be ready for human trials by the end of 2025, so they've been beaten to the large-scale human trials milestone by CEBSIT. Follow Tom's Hardware on Google News to get our up-to-date news, analysis, and reviews in your feeds. Make sure to click the Follow button.


Business Journals
an hour ago
- Business Journals
Meet the dental AI startup looks to revolutionize Florida's dentistry sector
A Boston-based startup is bringing artificial intelligence to Florida's dental offices, promising to transform how cavities are detected and diagnosed.


Hamilton Spectator
an hour ago
- Hamilton Spectator
Alberta doctors association raises concerns over Smith limiting free COVID vaccines
EDMONTON - The organization representing Alberta doctors is joining health-care worker unions in raising concerns over Premier Danielle Smith's decision to charge most Albertans for a COVID-19 vaccination this fall. Dr. Shelley Duggan, president of the Alberta Medical Association, says the policy leaves behind many seniors and health-care workers, and doesn't even mention pregnant individuals, First Nations, Inuit, Métis or members of other racialized groups. She says creating barriers to vaccination for the most high-need groups is counterproductive. The association head also notes pieces of the policy are counter to recommendations from Canada's National Advisory Committee on Immunization. However, Duggan says she appreciates that the government is encouraging measles vaccination. Smith says her government is looking to prevent wastage, recover costs, and target vaccinations to those who need them the most. This report by The Canadian Press was first published June 17, 2025. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .